Member Info for bobbust

Was changed from first purchase to first delivery.

They have sold more than just these

SCIB 1

At least 6 patients will have had a further scan.

There could be a further 6 patients who have had the week 13 scan.

Further details on the response rates between Cohort 1 and 2.

If Cohort 2 is at 80+‰ this will be huge as the combination of CPI ,I believe, results in worse side effects.

As it's open label we can have an update at any time.

Are people selling because of the time it is taking to get government funding?

“The stock market is a device for transferring money from the impatient to the patient"

Could there be something coming.

If there was on issue with the accounts how come they know it will be solved in two weeks?

From what little research I have done the CPI increase survival time for up to a year.

I don't think the CPI combo reduced tumour load by 90%

I may be wrong and someone here will know of results that show tumour shrinkage comparable to SCIB 1.

But if we are market leaders in tumour shrinkage then that is a whole new ball game

It's money for old rope.

Once it's up and running with one and they prove it works it could have a dramatic pick up by other miners

My guess is they are waiting for full production news in the hope that pushes the SP above 4p. Then the deal will go through quite quickly after that.

MC now equal to forthcoming payment.

All other investments free

Scancell have tried to tell you it works. Especially with CPI.

As a monotherpey my guess is it needs to be given early as per the mouse model.

This works and will be worth billions.

Selling to make 20% is silly

Strong data and more to follow

Surprise no mention of the tumor shrinkage

SCIB 1 is now worth the entire MC

Then there's everything else.

And don't forget SCIB 2 that is still there and CPI don't work that well in lung cancer

1.5 m today seams the wrong way round for a pump and dump

Tumour reduction at 37 weeks.. 87% to 94%

and people sell????

SCLP told us the results were going to be good in a previous RNS when they talked about the next stages for SCIB1 and the route to a phase 2 and 3 trial and on to commercialisation.

They just did it again with Modi 1.

That line was not needed!!!!!!!

This is going to be huge!!!!!!!

Read between the lines.

I know what I am doing for lunch.

Amazing

Strong language on the RNS.

Definitely feel that both Modi1 and SCIB 1 work well with CPI.

I do wonder if this actually a bonus in sales and marketing in the short to medium term.

CPI are well known and used it could be easier to sell them as a booster to CPI than start a whole new drug.

Sales could ramp up really quickly.

And if it increases the number of people who benefit from CPI. Their manufacturer will be pushing SCLP products as well

I thought the 1st HWM was moved for a few days to help the stuck HWM so a clean month should produce more than 30k.

Plus both now on two shifts.

Production could be significantly higher than 70k

Since 3 July.

Not a huge amount of money but definitely some buyers

Still think we are well under value

Tilly still had CPI in her blood from previous treatment when she received Modi 1.

She was not on the trial with CPI. Cohort 4.

I think you will find that in combination with CPI Modi 1 shrinks tumours.

The results of Cohort 4 and beyond will show this.